Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Huvudupphovsmän: | Davies, KE, Chamberlain, JS |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Springer Nature
2019
|
Liknande verk
Liknande verk
-
Therapeutic approaches to muscular dystrophy.
av: Goyenvalle, A, et al.
Publicerad: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
av: Guiraud, S, et al.
Publicerad: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
av: Fairclough, R, et al.
Publicerad: (2011) -
Progress in therapy for Duchenne muscular dystrophy
av: Fairclough, R, et al.
Publicerad: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
av: Potter, A, et al.
Publicerad: (2006)